期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

微生物来源的抗真菌抗生素的研究进展 被引量：3

Development in research of antifungal antibiotics derived from microorganisms
下载PDF
导出
摘要 近年来,随着真菌感染性问题的日趋严重,研究开发安全、新型和有效的抗真菌药物显得尤为重要。抗真菌药物根据其作用靶位分为抑制真菌细胞膜、细胞壁、蛋白质和核酸合成及抑制电子传递等5种类型。现从这5个方面对微生物来源的抗真菌抗生素研究进展作一概述。 With the problem of fungal infections getting increasingly serious,it's important to develop novel safe and effective antifungal drugs. According to defferent action targets including cell membrane, cell wall, protein, nucleic acid and electron transport, anti fungal antibiotics were divided into five types. The development in research of these five types of antibiotics derived from microorganisms was reviewed in this paper.
作者 殷瑜 黄为一 陈代杰
机构地区 南京农业大学微生物学系 上海来益生物药物研发中心
出处 《中国新药杂志》 CAS CSCD 北大核心 2004年第2期113-117,共5页 Chinese Journal of New Drugs
关键词 抗真菌抗生素 细胞膜 细胞壁 蛋白质 电子传递 核酸合成 antifungal antibiotics cell membrane cell wall protein electron transport nucleic acid synthesis
分类号 R978.5 [医药卫生—药品]
  • 相关文献

参考文献37

  • 1郝飞,叶庆佾.抗真菌药物作用靶位的研究进展[J].中国皮肤性病学杂志,2001,15(2):123-124. 被引量：3
  • 2Kelly SL,Lamb DC,Corran AJ,et al.Model of action and resistance to azole antifungals associated with the formation of 14α-methylergosta-8,24(28)-dien-3β,6α-diol[J].Biochem Biophys Res Commun,1995,207(3)∶910-915.
  • 3Georgopapadakou N,Walsh TJ.Antifungal agents:chemotherapeutic targets and immunoligic strategies[J].Antimicrob Agents Chemother,1996,40(2)∶279-291.
  • 4Ghannoum MA,Rice LB.Antifungal agents:mode of action,mechanisms of resitance,and correlation of these mechanisms with bacterial resistance[J].Clin Microbiol Rev,1999,12(4)∶501-517.
  • 5Holz RW.The effects of polyene antibiotics nystain and amphotericin B on the lipid membranes[J].Ann NY Acad Sci,1974,235(10)∶469-479.
  • 6Hsuchen CC,Feingold DF.Polyene antibiotic action on lecithin liposomes:effect of cholesterol and fatty acyl chains[J].Biochem Biophys Res Commun,1973,51(5)∶972-978.
  • 7Hugo VB.Mechanism of antifungal resistance[J].Rev Iberoam Micol,1997,14(1)∶44-49.
  • 8Michaelis S,Berkower C.Sequence comparison of yeast ATP binding cassette(ABC) proteins[J].Cold Spring Harbor Symp Quant Biol,1995,60∶291-307.
  • 9Hiemenz JW,Walsh TJ.Lipid formulations of amphotericin B[J].J Liposome Res,1998,8(5)∶443-467.
  • 10Rowles DM,Fraser SL.Amphotericin B lipid complex(ABLC)-associated hypertension:case report and review[J].Clin Infect Dis,1999,29(6)∶1564-1565.

二级参考文献10

  • 1[1]Groll AH, Lucca AJD, Walsh TJ. Emerging targets for the development of novel antifungal therapeutics [J]. Trend Microbiol,1998,6(3): 117～ 124
  • 2[2]Maertens JA, Boogaoerts MA. Fungal cell wall inhibitors emphasis on clinical aspects [J ]. Curr Pharm Des, 2000,6 (2): 225 ～239
  • 3[3]Kollar R, Reinhold BB, Petrakova E, et al.Architecture of the yeast cell wall. Beta( l-6)-glucan interconnects manoprotein, beta ( 1-3)-glucan, and chitin [ J ]. J Biol Chem,1997,272(28): 17762～17775
  • 4[4]Groll AH, Piscitelli SC, Walsh TJ. Clinical pharmacology of systemic antifungal agents:a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development [J ]. Adv Pharmatol,1998,44(2) :343 ～500
  • 5[5]Hanada K, Nishijima M, Fujita T, et al.Specificity of inhibitors of serine palmitoytransferase(SPT), a key enzyme in sphingolipid biosynthesis in infect cells. A novel evaluation system using an SPT-defective mammalian cell mutant [ J]. Biochem Pharmacol,2000,59(10). 1211 ～ 1216
  • 6[6]Mandalal SM, Harris GH. Isolation and characterization of novel inhibitors of sphingolipid synthesis: australifungin, viridiofungin, rustmicin, and Khafrefungin[J ]. Methods Enzymol, 2000,311 (3): 335 ～ 348
  • 7[7]In Y, Ishida T,Takesako K. Unique molecular conformation of aureobasidin A, a highly amide N methy lated cyclic depsipeptide with potent antifungal activity: X - ray crystal structure and molecular modeling studies[ J ]. J Pept Res, 1999,531 (3): 492～500
  • 8[8]Derlin DS, Seto- Yong D, Monk BC. The plasma membrane H -ATPase of fungi. A candidate drug targets[J ]? Ann N Y Acad Sci, 1997,834(3). 609 ～617
  • 9[9]Ahmad I, Perkins WR, Lupan DM, et al.Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity[J]. Biochim Biophys Acta, 1995, 1237(2): 109 ～ 114
  • 10[10]Persidis A. Antibacterial and antifungal drug discovery [J ]. Nat Biotechnol, 1999,17(11):1141 ～1142

共引文献2

同被引文献34

  • 1王亚男.抗真菌药物研究进展[J].国外医药（抗生素分册）,2005,26(2):59-63. 被引量：9
  • 2张杰,张双全.抗真菌肽对真菌作用机制研究进展[J].生物化学与生物物理进展,2005,32(1):13-17. 被引量：10
  • 3乔建军,刘伟,李若瑜.白念珠菌耐药的分子机制研究进展[J].微生物学通报,2007,34(2):393-396. 被引量：9
  • 4Zhong WY,Jeffries MW,Georgopapadakou NH.Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species[J].Antimicrob Ag Chemother,2000,44(3):651-3.
  • 5Ruiz-Herrera J,San-Blas G.Chitin synthesis as target for antifungal drugs[J].Curr Drug Targets Infect Disord 2003,3(1):77-91.
  • 6Citak S,Ozcelik B,Cesur S.In vitro suscep tibility of Cand idaspecies isolated from blood culture to some antifungal agents[J].Jpn J Infect Dis,2005,58(1):44-6.
  • 7Rock FL,Mao W,Anya YA,et al.An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site[J].Science,2007,316(5832):1759-61.
  • 8David SP.Resistance to echinocandin-class antifungal drugs[J].Drug Resistance Update,2007,10:121-130.
  • 9张华,董悦生,谷匡人,等.新的抗真菌化合物、制备方法及用途:中国,200410092443.4[P].2006-07-05.
  • 10Wong JH,Hao J,Cao Z,et al.An antifungal protein from Bacillus amyloliquefaciens[J].J Appl Microbiol,2008,105(6):1888-98.

引证文献3

二级引证文献5

中国新药杂志
2004年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部